Jean-Luc M. Lemercier, CVP, EMEACLA and JAPAC at Edwards Lifesciences Corp (EW), sold 28,800 shares at $84.11 ($2.4M) on 2024-05-01, disclosed to the SEC on 2024-05-01.
Scheduled sale ($2.4M) by CVP, EMEACLA and JAPAC under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $84.11 | 12,240 | $1.0M | 42.4% |
| 2 | $84.11 | 12,240 | $1.0M | 42.4% |
| 3 | $84.83 | 2,160 | $183K | 7.6% |
| 4 | $84.83 | 2,160 | $183K | 7.6% |
| Total | $84.22 avg | 28,800 | $2.4M | 100% |
| Filing → |
| EW | SELL | 2023-05-09 | $1.2M | — | Filing → |
| EW | SELL | 2023-04-06 | $552K | — | Filing → |
| EW | SELL | 2023-03-08 | $1.0M | — | Filing → |